SENP2 regulates mitochondrial function and insulin secretion in pancreatic β cells
1
조회
0
다운로드
1
인용
0
참고문헌
초록
Increasing evidence has shown that small ubiquitin-like modifier (SUMO) modification plays an important role in metabolic regulation. We previously demonstrated that SUMO-specific protease 2 (SENP2) is involved in lipid metabolism in skeletal muscle and adipogenesis. In this study, we investigated the function of SENP2 in pancreatic β cells by generating a β cell-specific knockout (Senp2-βKO) mouse model. Glucose tolerance and insulin secretion were significantly impaired in the Senp2-βKO mice. In addition, glucose-stimulated insulin secretion (GSIS) was decreased in the islets of the Senp2-βKO mice without a significant change in insulin synthesis. Furthermore, islets of the Senp2-βKO mice exhibited enlarged mitochondria and lower oxygen consumption rates, accompanied by lower levels of S616 phosphorylated DRP1 (an active form of DRP1), a mitochondrial fission protein. Using a cell culture system of NIT-1, an islet β cell line, we found that increased SUMO2/3 conjugation to DRP1 due to SENP2 deficiency suppresses the phosphorylation of DRP1, which possibly induces mitochondrial dysfunction. In addition, SENP2 overexpression restored GSIS impairment induced by DRP1 knockdown and increased DRP1 phosphorylation. Furthermore, palmitate treatment decreased phosphorylated DRP1 and GSIS in β cells, which was rescued by SENP2 overexpression. These results suggest that SENP2 regulates mitochondrial function and insulin secretion at least in part by modulating the phosphorylation of DRP1 in pancreatic β cells.
Abstract
Increasing evidence has shown that small ubiquitin-like modifier (SUMO) modification plays an important role in metabolic regulation. We previously demonstrated that SUMO-specific protease 2 (SENP2) is involved in lipid metabolism in skeletal muscle and adipogenesis. In this study, we investigated the function of SENP2 in pancreatic β cells by generating a β cell-specific knockout (Senp2-βKO) mouse model. Glucose tolerance and insulin secretion were significantly impaired in the Senp2-βKO mice. In addition, glucose-stimulated insulin secretion (GSIS) was decreased in the islets of the Senp2-βKO mice without a significant change in insulin synthesis. Furthermore, islets of the Senp2-βKO mice exhibited enlarged mitochondria and lower oxygen consumption rates, accompanied by lower levels of S616 phosphorylated DRP1 (an active form of DRP1), a mitochondrial fission protein. Using a cell culture system of NIT-1, an islet β cell line, we found that increased SUMO2/3 conjugation to DRP1 due to SENP2 deficiency suppresses the phosphorylation of DRP1, which possibly induces mitochondrial dysfunction. In addition, SENP2 overexpression restored GSIS impairment induced by DRP1 knockdown and increased DRP1 phosphorylation. Furthermore, palmitate treatment decreased phosphorylated DRP1 and GSIS in β cells, which was rescued by SENP2 overexpression. These results suggest that SENP2 regulates mitochondrial function and insulin secretion at least in part by modulating the phosphorylation of DRP1 in pancreatic β cells.
참고문헌 (42)
- Hickey, C. M., "Function and regulation of SUMO proteases", Nat. Rev. Mol. Cell Biol, 13, pp.755~766 (2012)
- Kamynina, E., "The roles of SUMO in metabolic regulation", Adv. Exp. Med. Biol, 963, pp.143~168 (2017)
- Oishi, Y., "SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPARdelta", Nat. Med, 14, pp.656~666 (2008)
- Chung, S. S., "SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor gamma in C2C12 myotubes", Biochem. J, 433, pp.155~161 (2011)
- Koo, Y. D., "SUMO-specific protease 2(SENP2)is an important regulator of fatty acid metabolism in skeletal muscle", Diabetes, 64, pp.2420~2431 (2015)
- Trajkovski, M., "Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells", J. Cell. Biol, 167, pp.1063~1074 (2004)
- Mziaut, H., "Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5", Nat. Cell Biol, 8, pp.435~445 (2006)
- Ferdaoussi, M., "SUMOylation and calcium control syntaxin-1A and secretagogin sequestration by tomosyn to regulate insulin exocytosis in human ss cells", Sci. Rep, 7, pp.248~ (2017)
- Dai, X. Q., "SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans", Diabetes, 60, pp.838~847 (2011)
- Ferdaoussi, M., "Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional beta cells", J. Clin. Invest, 125, pp.3847~3860 (2015)
- Maechler, P., "In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion", Int. J. Biochem. Cell Biol, 38, pp.696~709 (2006)
- Wollheim, C. B., "Beta-cell mitochondria in the regulation of insulin secretion : a new culprit in type II diabetes", Diabetologia, 43, pp.265~277 (2000)
- Silva, J. P., "Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes", Nat. Genet, 26, pp.336~340 (2000)
- Nicholas, L. M., "Mitochondrial transcription factor B2 is essential for mitochondrial and cellular function in pancreatic beta-cells", Mol. Metab, 6, pp.651~663 (2017)
- Twig, G., "Fission and selective fusion govern mitochondrial segregation and elimination by autophagy", EMBO J, 27, pp.433~446 (2008)
- Reinhardt, F., "Drp1 guarding of the mitochondrial network is important for glucose-stimulated insulin secretion in pancreatic beta cells", Biochem. Biophys. Res. Commun, 474, pp.646~651 (2016)
- Schultz, J., "Precise expression of Fis1 is important for glucose responsiveness of beta cells", J. Endocrinol, 230, pp.81~91 (2016)
- Hennings, T. G., "In vivo deletion of beta-cell Drp1 impairs insulin secretion without affecting islet oxygen consumption", Endocrinology, 159, pp.3245~3256 (2018)
- Park, K. S., "Selective actions of mitochondrial fission", fusion genes on metabolism-secretion coupling in insulin-releasing cells, 2008, pp.283, 33347~33356
- Jung, H. S., "Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa", Islets, 8, pp.207~216 (2016)
- Szot, G. L., "Murine pancreatic islet isolation", J. Vis. Exp, 7, pp.255~ (2007)
- Fu, J., "Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration", PLoS Genet, 10, pp.e1004579~ (2014)
- Kashatus, J. A., "Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth", Mol. Cell, 57, pp.537~551 (2015)
- Serasinghe, M. N., "Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors", Mol. Cell, 57, pp.521~536 (2015)
- Taguchi, N., "Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission", J. Biol. Chem, 282, pp.11521~11529 (2007)
- Mendler, L., "The ubiquitin-like SUMO system and heart function : from development to disease", Circ. Res, 118, pp.132~144 (2016)
- Figueroa-Romero, C., "SUMOylation of the mitochondrial fission protein Drp1occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle", FASEB. J, 23, pp.3917~3927 (2009)
- Jitrapakdee, S., "Regulation of insulin secretion : role of mitochondrial signalling", Diabetologia, 53, pp.1019~1032 (2010)
- Kwak, S. H., "Mitochondrial metabolism and diabetes", J. Diabetes Investig, 1, pp.161~169 (2010)
- Lowell, B. B., "Mitochondrial dysfunction and type 2 diabetes", Science, 307, pp.384~387 (2005)
- Kabra, U. D., "Direct substrate delivery into mitochondrial fission-deficient pancreatic islets rescues insulin secretion", Diabetes, 66, pp.1247~1257 (2017)
- Chang, C. R., "Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1", Ann. N. Y. Acad. Sci, 1201, pp.34~39 (2010)
- Liesa, M., "Mitochondrial dynamics in mammalian health and disease", Physiol. Rev, 89, pp.799~845 (2009)
- Guerra de Souza, A. C., "SUMO-regulated mitochondrial function in Parkinson’s disease", J. Neurochem, 137, pp.673~686 (2016)
- Prudent, J., "MAPL SUMOylation of Drp1 Stabilizes an ER", Mitochondrial platform required for cell death, 2015, pp.59, 941~955
- Zunino, R., "The SUMO protease SENP5 is required to maintain mitochondrial morphology and function", J. Cell Sci, 120, pp.1178~1188 (2007)
- Guo, C., "SENP3-mediated deSUMOylation of dynamin-related protein 1promotes cell death following ischaemia", EMBO J, 32, pp.1514~1528 (2013)
- Guo, C., "SENP3-mediated deSUMOylation of Drp1 facilitates interaction with Mffto promote cell death", Sci. Rep, 7, pp.43811~ (2017)
- Yao, Q., "SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses", J. Biol. Chem, 286, pp.27342~27349 (2011)
- Hietakangas, V., "PDSM, a motif for phosphorylation-dependent SUMO modification", Proc. Natl Acad. Sci. USA, 103, pp.45~50 (2006)
- Wikstrom, J. D., "AMPK regulates ER morphology and function in stressed pancreatic beta-cells via phosphorylation of DRP1", Mol. Endocrinol, 27, pp.1706~1723 (2013)
- Brouwers, B., "Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression", Cell Metab, 20, pp.979~990 (2014)